Final Overall Survival Analysis of the SOGUG Phase 2 MAJA Study: Maintenance Vinflunine Versus Best Supportive Care After First-Line Chemotherapy in Advanced Urothelial Carcinoma.

Autor: Bellmunt Molins J; Medical Oncology, Hospital del Mar, Barcelona, Spain; Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address: jbellmunt@imim.es., García-Donas Jiménez J; Medical Oncology, HM Hospitales, Centro Integral Oncológico HM Clara Campal, Madrid, Spain., Valderrama BP; Medical Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain., Virizuela Echaburu JA; Medical Oncology, Hospital Universitario Virgen de Macarena, Sevilla, Spain., Hernando-Polo S; Medical Oncology, Hospital Universitario Fundación Alcorcón, Alcorcón, Spain., Climent Durán MÁ; Medical Oncology, Instituto Valenciano de Oncología, Valencia, Spain., Villa-Guzmán JC; Medical Oncology, Hospital General Universitario de Ciudad Real, Ciudad Real, Spain., Arranz Arija JÁ; Medical Oncology, Hospital General Universitario Gregorio Marañón, Madrid, Spain., Ostiategui ML; Medical Oncology, Hospital General Universitario de Elda, Alicante, Spain., Milagro NL; Medical Oncology, Complejo Hospitalario de Navarra, Pamplona, Spain., González-Del-Alba A; Medical Oncology, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain., González BM; Medical Oncology Department, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain., Díaz EG; Oncology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spain., Gauna DC; Medical Oncology, CIBER-ONC, Hospital Universitario 12 de Octubre, Madrid, Spain., Santasusana MD; Medical Oncology, Althaia, Xarxa Assitencial de Manresa, Manresa, Spain., Herranz UA; Medical Oncology, Complejo Hospitalario Universitario de Santiago, Santiago de Compostela, Spain., Del Muro Solans XG; Medical Oncology, Institut Català d'Oncologia Hospitalet, IDIBELL, Universitat de Barcelona, Hospitalet de Llobregat, Spain., Pérez-Gracia JL; Medical Oncology, Clínica Universidad de Navarra, Pamplona, Spain., Vázquez JP; Medical Oncology, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), CIBERONC, Madrid, Spain., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain., Pous AF; Medical Oncology, Catalan Institute of Oncology, Badalona Applied Research Group in Oncology (B∙ARGO), IGTP, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.

Publikováno v: Clinical genitourinary cancer [Clin Genitourin Cancer] 2020 Dec; Vol. 18 (6), pp. 452-460. Date of Electronic Publication: 2020 May 11.

A phase II study of vinorelbine and estramustine in patients with hormone-resistant prostate cancer.

Autor: Carles Galcerán J; Oncology Unit, Hospital del Mar, 08003 Barcelona, Spain. jcarles@imas.imim.es, Bastus Piulats R, Martín-Broto J, Maroto Rey P, Nogué Aligué M, Domenech Santasusana M, Arcusa Lanza A, Bellmunt Molins J, Colin C, Girard A

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2005 Mar; Vol. 7 (2), pp. 66-73.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

[Diseases in mountain expeditions].

Autor: Bellmunt Molins J

Publikováno v: Medicina clinica [Med Clin (Barc)] 1997 Jun 14; Vol. 109 (3), pp. 116-7.

[Preliminary results of a phase II randomized controlled trial comparing M-VAC and M-CAVI in patients with bladder cancer (T2-4 N0-1 M0)].

Autor: Bellmunt Molins J; Sección de Oncología Médica y Servicio de Urología, Hospital General Universitario Vall d'Hebron, Barcelona, España., Ribas A, Albanell J, Lorente Garín JA, de Torres Mateos JA, Morote Robles J, López Palacios MA, Banús Gassol JM, Casado Cobo S, Eres N, Solé Calvo LA

Publikováno v: Archivos espanoles de urologia [Arch Esp Urol] 1996 Jun; Vol. 49 (5), pp. 465-72.